• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Severe Allograft Rejection and Autoimmune Hemolytic Anemia After Anti-PD1 Therapy in a Kidney Transplanted Patient.

作者信息

Deltombe Clément, Garandeau Claire, Renaudin Karine, Hourmant Maryvonne

机构信息

Nephrology and Immunology Department, Institute of Transplantation in Urology and Nephrology, Nantes University Hospital, Nantes, France.

Pathology Department, Institute of Transplantation in Urology and Nephrology, Nantes University Hospital, Nantes, France.

出版信息

Transplantation. 2017 Sep;101(9):e291. doi: 10.1097/TP.0000000000001861.

DOI:10.1097/TP.0000000000001861
PMID:29633980
Abstract
摘要

相似文献

1
Severe Allograft Rejection and Autoimmune Hemolytic Anemia After Anti-PD1 Therapy in a Kidney Transplanted Patient.肾移植患者接受抗PD1治疗后发生严重同种异体移植排斥反应和自身免疫性溶血性贫血
Transplantation. 2017 Sep;101(9):e291. doi: 10.1097/TP.0000000000001861.
2
Tumor Regression and Allograft Rejection after Administration of Anti-PD-1.抗PD-1给药后的肿瘤消退和同种异体移植排斥反应
N Engl J Med. 2016 Mar 3;374(9):896-8. doi: 10.1056/NEJMc1509268.
3
The successful use of pembrolizumab in a renal transplant recipient with metastatic melanoma.派姆单抗成功治疗肾移植受者转移性黑色素瘤。
Melanoma Res. 2020 Jun;30(3):321-324. doi: 10.1097/CMR.0000000000000651.
4
Antitumor activity of nivolumab on hemodialysis after renal allograft rejection.尼伏单抗对肾移植排斥后血液透析患者的抗肿瘤活性。
J Immunother Cancer. 2016 Oct 18;4:64. doi: 10.1186/s40425-016-0171-8. eCollection 2016.
5
Immunotherapy-associated autoimmune hemolytic anemia.免疫治疗相关自身免疫性溶血性贫血。
J Immunother Cancer. 2017 Feb 21;5:15. doi: 10.1186/s40425-017-0214-9. eCollection 2017.
6
Pembrolizumab for metastatic melanoma in a renal allograft recipient with subsequent graft rejection and treatment response failure: a case report.帕博利珠单抗治疗肾移植受者转移性黑色素瘤后出现移植排斥反应及治疗反应失败：一例报告
J Med Case Rep. 2017 Mar 19;11(1):73. doi: 10.1186/s13256-017-1229-z.
7
PD-1 Inhibitor Immune-Related Adverse Events in Patients With Preexisting Endocrine Autoimmunity.PD-1 抑制剂免疫相关不良事件在伴有内分泌自身免疫的患者中的表现。
J Clin Endocrinol Metab. 2018 Oct 1;103(10):3589-3592. doi: 10.1210/jc.2018-01430.
8
Use of Ipilimumab and Pembrolizumab in Metastatic Melanoma in a Combined Heart and Kidney Transplant Recipient: A Case Report.伊匹木单抗和帕博利珠单抗在心脏和肾脏联合移植受者转移性黑色素瘤中的应用：一例报告
Transplant Proc. 2020 Mar;52(2):657-659. doi: 10.1016/j.transproceed.2019.09.014. Epub 2020 Feb 8.
9
Checkpoint Inhibitor-Induced Rejection of a Liver Allograft: A Combination of Acute T Cell-Mediated and Antibody-Mediated Rejection.检查点抑制剂诱导的肝移植排斥反应：急性T细胞介导和抗体介导排斥反应的联合
Liver Transpl. 2019 Dec;25(12):1845-1848. doi: 10.1002/lt.25622. Epub 2019 Sep 25.
10
Autoimmune hemolytic anemia induced by anti-PD-1 therapy in metastatic melanoma.抗PD-1治疗转移性黑色素瘤所致的自身免疫性溶血性贫血
Melanoma Res. 2016 Apr;26(2):202-4. doi: 10.1097/CMR.0000000000000232.

引用本文的文献

1
Immune Checkpoint Inhibitors and Allograft Rejection Risk: Emerging Evidence Regarding Their Use in Kidney Transplant Recipients.免疫检查点抑制剂与同种异体移植排斥风险：关于其在肾移植受者中应用的新证据
J Clin Med. 2025 Jul 20;14(14):5152. doi: 10.3390/jcm14145152.
2
Use of immune checkpoint inhibitors in solid organ transplant recipients with advanced cutaneous malignancies.免疫检查点抑制剂在患有晚期皮肤恶性肿瘤的实体器官移植受者中的应用。
Front Transplant. 2023 Oct 30;2:1284740. doi: 10.3389/frtra.2023.1284740. eCollection 2023.
3
Donor Derived Cell Free DNA in Kidney Transplantation: The Circa 2020-2021 Update.
供体游离 DNA 在肾移植中的应用：2020-2021 年进展。
Transpl Int. 2022 Jun 1;35:10448. doi: 10.3389/ti.2022.10448. eCollection 2022.
4
Gene Expression Profiling in Kidney Transplants with Immune Checkpoint Inhibitor-Associated Adverse Events.免疫检查点抑制剂相关不良事件的肾移植中的基因表达谱分析。
Clin J Am Soc Nephrol. 2021 Sep;16(9):1376-1386. doi: 10.2215/CJN.00920121. Epub 2021 Jul 9.
5
Acute renal transplant rejection following nivolumab therapy for metastatic melanoma.纳武单抗治疗转移性黑色素瘤后发生急性肾移植排斥反应。
BMJ Case Rep. 2021 Feb 8;14(2):e238037. doi: 10.1136/bcr-2020-238037.
6
Diagnosis and Management of Hematological Adverse Events Induced by Immune Checkpoint Inhibitors: A Systematic Review.免疫检查点抑制剂所致血液学不良事件的诊断与管理：系统评价。
Front Immunol. 2020 Oct 21;11:1354. doi: 10.3389/fimmu.2020.01354. eCollection 2020.
7
The Use of Immune Checkpoint Inhibitors in Oncology and the Occurrence of AKI: Where Do We Stand?免疫检查点抑制剂在肿瘤学中的应用与 AKI 的发生：我们处于什么位置？
Front Immunol. 2020 Oct 8;11:574271. doi: 10.3389/fimmu.2020.574271. eCollection 2020.
8
Pembrolizumab-induced pancytopenia in a patient with squamous cell lung cancer.帕博利珠单抗致肺鳞癌患者全血细胞减少。
Thorac Cancer. 2020 Sep;11(9):2731-2735. doi: 10.1111/1759-7714.13582. Epub 2020 Aug 7.
9
Early T cell infiltration is modulated by programed cell death-1 protein and its ligand (PD-1/PD-L1) interactions in murine kidney transplants.早期 T 细胞浸润受程序性细胞死亡蛋白 1 及其配体（PD-1/PD-L1）相互作用在小鼠肾移植中的调节。
Kidney Int. 2020 Oct;98(4):897-905. doi: 10.1016/j.kint.2020.03.037. Epub 2020 Apr 25.
10
Clinical Characteristics and Treatment of Immune-Related Adverse Events of Immune Checkpoint Inhibitors.免疫检查点抑制剂免疫相关不良事件的临床特征与治疗
Immune Netw. 2020 Feb 17;20(1):e9. doi: 10.4110/in.2020.20.e9. eCollection 2020 Feb.